Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Early Pulmonary Rehabilitation After Hospitalisation for Acute Exacerbation COPD
This is a study to evaluate the effects of early pulmonary rehabilitation within 10 days after discharge from the hospital after a COPD exacerbation on exercise tolerance, exacerbations, re-admissions and the quality of life during 6 months.
Study Design:
One hundred patients with an acute exacerbation of COPD admitted to the regular pulmonology
department via the emergency room will be recruited after they have given written informed
consent. Inclusion criteria are an age > 40 years or ≤ 80 years, at least 10 pack years of
smoking history and COPD at least GOLD II. Each form of physical therapy is accepted outside
pulmonary rehabilitation. Exclusion criteria include participation in a pulmonary
rehabilitation program in the preceding year, comorbidity that can limit exercise training
(for example: invalidating ischaemic heart disease, RA, malignancy and lung embolus),
intolerance to prednisone, history of asthma, non-compliance, findings on chest radiography
other than fitting with signs of COPD and a prior randomisation. During admission patients
will receive standard exacerbation COPD treatment consisting of O2, combivent inhalation,
antibiotics and prednisone. Exercise capacity is measured by a 6 minute walk test performed
at discharge. The COPD GOLD classification is detected with a spirometry after completion of
exacerbation therapy and before randomisation and discharge.
Both measurements are repeated after completion of the pulmonary rehabilitation program at 3
months. Quality of life is evaluated by the following questionnaires at discharge: St.
George respiratory questionnaire (SGRQ), SF-36-scores (short form health survey) and
clinical COPD questionnaire (CCQ). Before discharge, patients are randomised with a computer
minimisation program for pulmonary rehabilitation or usual care with special attendance to
age (< 70 years or ≥ 70 years), sex, length of hospital stay (< 7 days or ≥ 7 days), six
minute walk test distance at discharge (< 100 or ≥ 100 meters) and predicted forced
expiratory volume in one second (FEV1< or ≥ FEV1). Pulmonary rehabilitation will take place
within ten days after discharge and shall be given by a multidisciplinary team
(pulmonologist, respiratory nurse, physical therapist, dietician and a social worker). The
program will last 2 hours weekly; 1 hour exercise training and one hour education during 8
weeks. All patients are followed up after discharge at 3 and 6 months. These questionnaires
will be repeated after accomplishment of the pulmonary rehabilitation program at day 90 and
day 180. Readmission rate will be also evaluated in this period.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|